https://www.selleckchem.com/pr....oducts/Mubritinib-TA
Children who were diagnosed with type 1 diabetes had increased school absenteeism 4 months before diagnosis. To compare effects of the dipeptidyl peptidase 4 (DPP-4) inhibitor linagliptin with those of a sulfonylurea on renal physiology in metformin-treated patients with type 2 diabetes mellitus (T2DM). In this double-blind randomized trial, 46 overweight T2DM patients without renal impairment received once-daily linagliptin (5 mg) or glimepiride (1 mg) for 8 weeks. Fasting glomerular filtration rate (GFR) and effective renal
Curtir
Comentario
Compartilhar
